Aripiprazole-induced reversible myopia in a patient with tourette syndrome

Andrea E. Cavanna; Elisa Capriolo; Virginia Caimi; Gabriele Arienti; Anna Riva; Renata Nacinovich; Stefano Seri

doi:10.1007/s10072-025-08496-x

Aripiprazole-induced reversible myopia in a patient with tourette syndrome

Andrea E. Cavanna^*
, Elisa Capriolo
, Virginia Caimi
, Gabriele Arienti
, Anna Riva
, Renata Nacinovich
, Stefano Seri

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

1 Citation (SciVal)

1 Downloads (Pure)

Abstract

Background: Myopia has been reported as a rare adverse effect of aripiprazole, a third-generation antidopaminergic medication used for the treatment of different neuropsychiatric conditions, including psychotic disorders, affective disorders, and obsessive-compulsive disorder. Case description: We document the rare case of a 29-year-old woman diagnosed with a neurodevelopmental tic disorder (Tourette syndrome) who developed bilateral myopia while taking aripiprazole 15 mg daily as a first-line anti-tic agent. Her myopia completely regressed following a decrease in the dose of aripiprazole from 15 mg to 10 mg daily. Discussion: To date, a total of 11 cases presenting with aripiprazole-induced reversible myopia (9 females, age range 19–34 years) have been reported. In addition to broadening the spectrum of the treated conditions, our case report raises the possibility of dose-dependent mechanisms underlying the development of myopia, at least in selected cases.

Original language	English
Pages (from-to)	6027-6030
Number of pages	4
Journal	Neurological Sciences
Volume	46
Issue number	11
Early online date	16 Sept 2025
DOIs	https://doi.org/10.1007/s10072-025-08496-x
Publication status	Published - 1 Nov 2025

Bibliographical note

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicateif changes were made. The images or other third party material in thisarticle are included in the article’s Creative Commons licence, unlessindicated otherwise in a credit line to the material. If material is notincluded in the article’s Creative Commons licence and your intendeduse is not permitted by statutory regulation or exceeds the permitteduse, you will need to obtain permission directly from the copyrightholder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/

Keywords

Tourette syndrome
Tics
Myopia
Aripiprazole

Access to Document

10.1007/s10072-025-08496-xLicence: CC BY 4.0

Aripiprazole-induced reversible myopia in a patient with tourette syndrome
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicateif changes were made. The images or other third party material in thisarticle are included in the article’s Creative Commons licence, unlessindicated otherwise in a credit line to the material. If material is notincluded in the article’s Creative Commons licence and your intendeduse is not permitted by statutory regulation or exceeds the permitteduse, you will need to obtain permission directly from the copyrightholder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/
Licence: CC BY 4.0

Cite this

@article{263bf07194f0475ba7c1eeaf7fa360fc,

title = "Aripiprazole-induced reversible myopia in a patient with tourette syndrome",

abstract = "Background: Myopia has been reported as a rare adverse effect of aripiprazole, a third-generation antidopaminergic medication used for the treatment of different neuropsychiatric conditions, including psychotic disorders, affective disorders, and obsessive-compulsive disorder. Case description: We document the rare case of a 29-year-old woman diagnosed with a neurodevelopmental tic disorder (Tourette syndrome) who developed bilateral myopia while taking aripiprazole 15 mg daily as a first-line anti-tic agent. Her myopia completely regressed following a decrease in the dose of aripiprazole from 15 mg to 10 mg daily. Discussion: To date, a total of 11 cases presenting with aripiprazole-induced reversible myopia (9 females, age range 19–34 years) have been reported. In addition to broadening the spectrum of the treated conditions, our case report raises the possibility of dose-dependent mechanisms underlying the development of myopia, at least in selected cases.",

keywords = "Tourette syndrome, Tics, Myopia, Aripiprazole",

author = "Cavanna, \{Andrea E.\} and Elisa Capriolo and Virginia Caimi and Gabriele Arienti and Anna Riva and Renata Nacinovich and Stefano Seri",

note = "This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicateif changes were made. The images or other third party material in thisarticle are included in the article{\textquoteright}s Creative Commons licence, unlessindicated otherwise in a credit line to the material. If material is notincluded in the article{\textquoteright}s Creative Commons licence and your intendeduse is not permitted by statutory regulation or exceeds the permitteduse, you will need to obtain permission directly from the copyrightholder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/",

year = "2025",

month = nov,

day = "1",

doi = "10.1007/s10072-025-08496-x",

language = "English",

volume = "46",

pages = "6027--6030",

journal = "Neurological Sciences",

issn = "1590-1874",

publisher = "Springer-Verlag Italia Srl",

number = "11",

}

TY - JOUR

T1 - Aripiprazole-induced reversible myopia in a patient with tourette syndrome

AU - Cavanna, Andrea E.

AU - Capriolo, Elisa

AU - Caimi, Virginia

AU - Arienti, Gabriele

AU - Riva, Anna

AU - Nacinovich, Renata

AU - Seri, Stefano

N1 - This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicateif changes were made. The images or other third party material in thisarticle are included in the article’s Creative Commons licence, unlessindicated otherwise in a credit line to the material. If material is notincluded in the article’s Creative Commons licence and your intendeduse is not permitted by statutory regulation or exceeds the permitteduse, you will need to obtain permission directly from the copyrightholder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/

PY - 2025/11/1

Y1 - 2025/11/1

N2 - Background: Myopia has been reported as a rare adverse effect of aripiprazole, a third-generation antidopaminergic medication used for the treatment of different neuropsychiatric conditions, including psychotic disorders, affective disorders, and obsessive-compulsive disorder. Case description: We document the rare case of a 29-year-old woman diagnosed with a neurodevelopmental tic disorder (Tourette syndrome) who developed bilateral myopia while taking aripiprazole 15 mg daily as a first-line anti-tic agent. Her myopia completely regressed following a decrease in the dose of aripiprazole from 15 mg to 10 mg daily. Discussion: To date, a total of 11 cases presenting with aripiprazole-induced reversible myopia (9 females, age range 19–34 years) have been reported. In addition to broadening the spectrum of the treated conditions, our case report raises the possibility of dose-dependent mechanisms underlying the development of myopia, at least in selected cases.

AB - Background: Myopia has been reported as a rare adverse effect of aripiprazole, a third-generation antidopaminergic medication used for the treatment of different neuropsychiatric conditions, including psychotic disorders, affective disorders, and obsessive-compulsive disorder. Case description: We document the rare case of a 29-year-old woman diagnosed with a neurodevelopmental tic disorder (Tourette syndrome) who developed bilateral myopia while taking aripiprazole 15 mg daily as a first-line anti-tic agent. Her myopia completely regressed following a decrease in the dose of aripiprazole from 15 mg to 10 mg daily. Discussion: To date, a total of 11 cases presenting with aripiprazole-induced reversible myopia (9 females, age range 19–34 years) have been reported. In addition to broadening the spectrum of the treated conditions, our case report raises the possibility of dose-dependent mechanisms underlying the development of myopia, at least in selected cases.

KW - Tourette syndrome

KW - Tics

KW - Myopia

KW - Aripiprazole

UR - https://link.springer.com/article/10.1007/s10072-025-08496-x

U2 - 10.1007/s10072-025-08496-x

DO - 10.1007/s10072-025-08496-x

M3 - Article

SN - 1590-1874

VL - 46

SP - 6027

EP - 6030

JO - Neurological Sciences

JF - Neurological Sciences

IS - 11

ER -

Aripiprazole-induced reversible myopia in a patient with tourette syndrome

Abstract

Bibliographical note

Keywords

Access to Document

Other files and links

Fingerprint

Cite this